December 21, 2017 / 12:00 PM / 9 months ago

BRIEF-Zomedica Pharma Enters License And Supply Agreement With Celsee For Cancer Liquid Biopsy Platform

Dec 21 (Reuters) - Zomedica Pharmaceuticals Corp:

* ZOMEDICA PHARMACEUTICALS CORP. ENTERS INTO LICENSE AND SUPPLY AGREEMENT WITH CELSEE, INC. FOR CANCER LIQUID BIOPSY PLATFORM

* ZOMEDICA PHARMACEUTICALS CORP - EXPECTS TO COMMENCE CLINICAL VALIDATION OF CELSEE’S CTC DETECTION TECHNOLOGY IN FIRST HALF OF 2018

* ZOMEDICA PHARMACEUTICALS CORP - EXPECTS TO COMMENCE MARKETING OF ZM-017 DURING SECOND HALF OF 2018

* ZOMEDICA PHARMACEUTICALS - CO TO HAVE ANIMAL HEALTH GLOBAL RIGHTS TO DEVELOP & MARKET CELSEE’S LIQUID BIOPSY PLATFORM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below